help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juge-Aubry, C. E.
Right arrow Articles by Meier, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juge-Aubry, C. E.
Right arrow Articles by Meier, C. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 6 2652-2658
Copyright © 2004 by The Endocrine Society


Obesity: Original Article

Regulatory Effects of Interleukin (IL)-1, Interferon-ß, and IL-4 on the Production of IL-1 Receptor Antagonist by Human Adipose Tissue

Cristiana E. Juge-Aubry, Emmanuel Somm, Rachel Chicheportiche, Danielle Burger, Agnès Pernin, Brigitte Cuénod-Pittet, Pierre Quinodoz, Vittorio Giusti, Jean-Michel Dayer and Christoph A. Meier

Endocrine Unit, Division of Endocrinology, Diabetes and Nutrition, Department of Internal Medicine (C.E.J.-A., E.S., A.P., C.A.M.); Hans Wilsdorf Laboratory, Division of Immunology and Allergy, Department of Internal Medicine (R.C., D.B., J.-M.D.); and Plastic Reconstructive Surgery Unit, Division of Reconstructive Surgery, Department of Surgery (B.C.-P.), University Hospital, CH-1211 Geneva 14, Switzerland; La Tour Hospital (P.Q.), CH-1217 Meyrin, Switzerland; and Division of Endocrinology, Diabetology and Metabolism, Department of Medicine (V.G.), University Hospital, CH-1011 Lausanne, Switzerland

Address all correspondence and requests for reprints to: Dr. Christoph A. Meier, Endocrine Unit, University Hospital Geneva, 24, rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: Christoph.Meier{at}medecine.unige.ch.

Adipose tissue is the source of production and site of action of several pro- and antiinflammatory cytokines. We have recently shown that white adipose tissue (WAT) is a major producer of the antiinflammatory IL-1 receptor antagonist (IL-1Ra). Because IL-1Ra serum levels are elevated 7-fold in human obesity and an excess of this protein has been implicated in the acquired resistance to leptin and insulin, we investigated the regulation of IL-1Ra in human WAT.

We demonstrate that IL-1Ra is mainly produced by adipocytes, rather than the stromal fraction of WAT, and that IL-1{alpha} and ß, as well as interferon-ß (IFN-ß), strongly up-regulate the expression and secretion of IL-1Ra in WAT. Moreover, human WAT expresses the receptors and proteins known to be required for the action of IL-1 (IL-1 receptor type I, IL-1 receptor accessory protein) and IFN-ß (IFN-{alpha}/ß receptor subunits 1 and 2). Finally, human WAT actively secretes these regulatory cytokines, suggesting that they up-regulate IL-1Ra through a local autocrine/paracrine action, which is hypothesized to play a regulatory role in adipogenesis and metabolism.

This work was supported by the Swiss National Science Foundation Grants 3200-064078 0.01 (to C.A.M.) and 32-68286.02 (to J.-M.D.), as well as by a grant from the Hans Wilsdorf Foundation (to D.B. and C.A.M.).

C.E.J.-A. and E.S. contributed equally to this work.

Abbreviations: BMI, Body mass index; FBS, fetal bovine serum; IFN, interferon; IFNAR1 and IFNAR2, IFN-{alpha} and -ß receptor subunit 1 and 2; IL-1Ra, IL-1 receptor antagonist; IL-1RAcP, IL-1 receptor-associated protein; IL-1RI and II, IL-1 receptor type I and II; LPS, lipopolysaccharide; PMA, phorbol myristate acetate; WAT, white adipose tissue.




This article has been cited by other articles:


Home page
J ANIM SCIHome page
G. J. Hausman, C. R. Barb, and R. G. Dean
Patterns of gene expression in pig adipose tissue: Transforming growth factors, interferons, interleukins, and apolipoproteins
J Anim Sci, October 1, 2007; 85(10): 2445 - 2456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Maury, K. Ehala-Aleksejev, Y. Guiot, R. Detry, A. Vandenhooft, and S. M. Brichard
Adipokines oversecreted by omental adipose tissue in human obesity
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E656 - E665.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Ortiz, M. DuTreil, C. Fattman, A. C. Pandey, G. Torres, K. Go, and D. G. Phinney
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury
PNAS, June 26, 2007; 104(26): 11002 - 11007.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Jager, T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti
Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
Endocrinology, January 1, 2007; 148(1): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Strandberg, M. Lorentzon, A. Hellqvist, S. Nilsson, V. Wallenius, C. Ohlsson, and J.-O. Jansson
Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2749 - 2754.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J.-M. DAYER, R. CHICHEPORTICHE, C. JUGE-AUBRY, and C. MEIER
Adipose Tissue Has Anti-Inflammatory Properties: Focus on IL-1 Receptor Antagonist (IL-1Ra)
Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 444 - 453.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Somm, E. Henrichot, A. Pernin, C. E. Juge-Aubry, P. Muzzin, J.-M. Dayer, M. J.H. Nicklin, and C. A. Meier
Decreased Fat Mass in Interleukin-1 Receptor Antagonist-Deficient Mice: Impact on Adipogenesis, Food Intake, and Energy Expenditure
Diabetes, December 1, 2005; 54(12): 3503 - 3509.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Menghini, V. Marchetti, M. Cardellini, M. L. Hribal, A. Mauriello, D. Lauro, P. Sbraccia, R. Lauro, and M. Federici
Phosphorylation of GATA2 by Akt Increases Adipose Tissue Differentiation and Reduces Adipose Tissue-Related Inflammation: A Novel Pathway Linking Obesity to Atherosclerosis
Circulation, April 19, 2005; 111(15): 1946 - 1953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society